{"id":"azimilide","rwe":[],"tags":[{"label":"azimilide","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Potassium voltage-gated channel subfamily H member 2","category":"target"},{"label":"KCNH2","category":"gene"},{"label":"Active","category":"status"},{"label":"Anti-Arrhythmia Agents","category":"pharmacology"},{"label":"Calcium Channel Blockers","category":"pharmacology"},{"label":"Calcium-Regulating Hormones and Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Membrane Transport Modulators","category":"pharmacology"}],"phase":"phase_3","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["azimilide hydrochloride","azimilide dihydrochloride","azimilide","azimilide HCl"],"offLabel":[],"synonyms":["azimilide hydrochloride","azimilide dihydrochloride","azimilide","azimilide HCl"],"timeline":[],"ecosystem":[],"mechanism":{"target":"Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily H member 2, Potassium voltage-gated channel subfamily KQT member 1","targets":[{"gene":"KCNH2","source":"DrugCentral","target":"Potassium voltage-gated channel subfamily H member 2","protein":"Potassium voltage-gated channel subfamily H member 2"}],"modality":"Small Molecule","drugClass":"azimilide","explanation":"Think of your heart as a pump that beats in a regular rhythm. Potassium channels help control how fast the heart beats. AZIMILIDE blocks these channels, which helps to slow down the heart rate and prevent irregular rhythms.","oneSentence":"AZIMILIDE works by blocking potassium channels in the heart, which helps to regulate heart rhythm.","technicalDetail":"AZIMILIDE acts as a selective blocker of the hERG potassium channel, which is involved in the repolarization phase of the cardiac action potential, thereby prolonging the QT interval and reducing the risk of arrhythmias."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/274","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=AZIMILIDE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=AZIMILIDE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:48:06.700231","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:39:29.917481+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[{"drugName":"abemaciclib","drugSlug":"abemaciclib","fdaApproval":"2017-09-28","patentExpiry":"Sep 28, 2031","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"alosetron","drugSlug":"alosetron","fdaApproval":"2000-02-09","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"amitriptyline","drugSlug":"amitriptyline","fdaApproval":"1961-04-07","genericCount":33,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"amodiaquine","drugSlug":"amodiaquine","fdaApproval":"","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"aripiprazole","drugSlug":"aripiprazole","fdaApproval":"2002-11-15","patentExpiry":"Sep 24, 2033","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"arsenic trioxide","drugSlug":"arsenic-trioxide","fdaApproval":"2000-09-25","genericCount":11,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"asciminib","drugSlug":"asciminib","fdaApproval":"2021-10-29","patentExpiry":"Oct 29, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-target"},{"drugName":"atomoxetine","drugSlug":"atomoxetine","fdaApproval":"2002-11-26","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"azimilide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"abemaciclib","brandName":"abemaciclib","genericName":"abemaciclib","approvalYear":"2017","relationship":"same-target"},{"drugId":"alosetron","brandName":"alosetron","genericName":"alosetron","approvalYear":"2000","relationship":"same-target"},{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-target"},{"drugId":"amitriptyline","brandName":"amitriptyline","genericName":"amitriptyline","approvalYear":"1961","relationship":"same-target"},{"drugId":"amodiaquine","brandName":"amodiaquine","genericName":"amodiaquine","approvalYear":"","relationship":"same-target"},{"drugId":"aripiprazole","brandName":"aripiprazole","genericName":"aripiprazole","approvalYear":"2002","relationship":"same-target"},{"drugId":"arsenic-trioxide","brandName":"arsenic trioxide","genericName":"arsenic trioxide","approvalYear":"2000","relationship":"same-target"},{"drugId":"asciminib","brandName":"asciminib","genericName":"asciminib","approvalYear":"2021","relationship":"same-target"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-target"},{"drugId":"atomoxetine","brandName":"atomoxetine","genericName":"atomoxetine","approvalYear":"2002","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT00752596","phase":"PHASE2","title":"Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2005-09","conditions":["Congestive Heart Failure"],"enrollment":1,"completionDate":"2006-07"},{"nctId":"NCT00751738","phase":"PHASE3","title":"Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2002-10","conditions":["Arrhythmias"],"enrollment":330,"completionDate":"2005-10"},{"nctId":"NCT00318838","phase":"PHASE1","title":"Effect of Azimilide Dihydrochloride on Renal Function","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2006-04","conditions":["Healthy"],"enrollment":21,"completionDate":"2006-05"},{"nctId":"NCT01464476","phase":"PHASE3","title":"Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)","status":"TERMINATED","sponsor":"Forest Laboratories","startDate":"2011-11","conditions":["Arrhythmias, Cardiac","Heart Diseases","Cardiovascular Diseases","Implantable Cardioverter Defibrillator"],"enrollment":240,"completionDate":"2013-06"},{"nctId":"NCT00035451","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2001-02","conditions":["Atrial Fibrillation"],"enrollment":658,"completionDate":"2003-06"},{"nctId":"NCT00035490","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2001-09","conditions":["Arrhythmia"],"enrollment":633,"completionDate":"2004-04"},{"nctId":"NCT00035477","phase":"PHASE3","title":"Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2000-09","conditions":["Atrial Fibrillation"],"enrollment":446,"completionDate":"2003-10"},{"nctId":"NCT00035464","phase":"PHASE3","title":"Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2000-12","conditions":["Atrial Fibrillation"],"enrollment":431,"completionDate":"2004-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"74QU6P2934","CHEBI":"CHEBI:34545","INN_ID":"7299","UMLSCUI":"C0252416","ChEMBL_ID":"CHEMBL123558","KEGG_DRUG":"D03037","DRUGBANK_ID":"DB04957","PUBCHEM_CID":"9571003","IUPHAR_LIGAND_ID":"2588","SECONDARY_CAS_RN":"149888-94-8","MESH_SUPPLEMENTAL_RECORD_UI":"C086123"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"79.0 hours","clearance":"2.4 mL/min/kg","fractionUnbound":"0.06%","volumeOfDistribution":"13.0 L/kg"},"publicationCount":166,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"AZIMILIDE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":0,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:39:29.917481+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}